The present invention relates to a genetically modified hematopoietic stem cellrn(HSC) comprising, in at least one ?-globin gene comprised in the genome thereof, at least rnone transgene encoding a functional ?-like globin protein, the said transgene being placed rnunder the control of the endogenous promoter of the said at least one ?-globin gene